Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10353 - 10360 of 12018 results
Calling All Boards of Directors: Four Recommendations from the SEC
June 13, 2014| Blog| Viewpoint
Equity Begets Flexibility: Valuing a Secured Creditor’s Claim in Bankruptcy and Allocating Post-Petition Interest
June 13, 2014| Advisory| Viewpoint
U.S. Supreme Court: Pom's Mislabeling Suit Against Coke Not Precluded by FDA Regulations
June 13, 2014| Blog| Viewpoint
Proposed Counterfeit Parts Rule Would Expand Coverage to Commercial Products Sold to Any Federal Agency
June 13, 2014| Blog| Viewpoint
No Quorum at Senate Nominations Hearing for CPSC's Adler; Three CPSC Nominees Now Waiting for Committee Action
June 12, 2014| Blog| Viewpoint
U.S. Supreme Court Allows Pom Wonderful to Pursue Lanham Act Claims against Coca-Cola
June 12, 2014| Blog| Viewpoint
D&O Insurance and IPOs: Seven Issues You Need to Consider
June 11, 2014| Blog| Viewpoint
UK High Court confirms jurisdiction to grant cross-border declaration of non-infringement
June 11, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised the underwriters in connection with a $230 million public offering by Cogent Biosciences, Inc. of 25,555,556 shares of common stock, which includes 3,333,333 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering were approximately $230 million, including proceeds from the exercise in full by the underwriters of the option to purchase additional shares, before deducting underwriting discounts and commissions and other offering expenses.
Mintz advised the underwriters in connection with a $200 million public offering by Soleno Therapeutics, Inc. of 2,352,941 shares of its common stock at a price to the public of $85.00 per share. The gross proceeds to Soleno from the offering were approximately $200 million before deducting underwriting discounts and commissions and other offering expenses. In addition, Soleno granted the underwriters a 30-day option to purchase up to an additional 352,941 shares of its common stock at the public offering price.
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|